LipoTrue Unveils Trio of Biotechnological Actives at in-cosmetics Asia 2026
Biotech firm LipoTrue has expanded its ingredient portfolio with the launch of Glintarine, Red Aternaliss, and Kalizyme, as reported by Cosmetics Business. Debuting at in-cosmetics Asia 2026, the three new actives utilize marine fermentation, plant-based biofactories, and biomimetic science to address specific skin concerns ranging from pigment redistribution to genomic protection and enzymatic exfoliation.
Context from Industry Pulse
The 2026 launch at in-cosmetics Asia highlights LipoTrue's focus on diversifying its biotechnology platforms. By utilizing marine ferments, stem cell hybrids, and biomimetic enzymes, the firm is moving toward highly specific biological targets like melanin redistribution and genomic protection. This strategy aligns with the broader industry focus on precision skincare, where ingredients are expected to perform multiple roles, such as Kalizyme’s simultaneous exfoliation and regeneration. The use of Wild Plants as Biofactories technology further emphasizes a shift toward sustainable, plant-derived production methods for complex enzymes that were previously difficult to replicate in cosmetic formats.
"The innovations combine marine biotechnology, plant-based technologies and biomimetic science to address three key areas of skin care: radiance, longevity and epidermal renewal."
The introduction of Glintarine marks an expansion into marine-inspired radiance solutions. According to Cosmetics Business, this ferment is modeled after the sea surface microlayer and targets melanin dynamics within the epidermis. The active is designed to facilitate pigment clearance and redistribution while offering antioxidant and exfoliating benefits. Early performance data suggests that the ingredient can produce visible improvements in skin smoothness and brightness within one week of application.
Longevity and cellular resilience are addressed through the launch of Red Aternaliss. As Cosmetics Business reports, this ingredient is a hybrid of red algae extracts and Edelweiss stem cells. The formulation is intended to target the nine hallmarks of aging by supporting genomic protection and epidermal integrity. By enhancing the skin’s regenerative capacity and cellular resilience, the active aims to maintain functional skin health and a younger appearance over extended periods.
LipoTrue also showcased Kalizyme, which utilizes the company's proprietary plant-based biofactory technology. Cosmetics Business notes that this active is a biomimetic version of the human KLK7 enzyme. It is engineered to replicate the natural desquamation process of the skin, providing a controlled exfoliation method that prioritizes user comfort. The dual-action approach combines the removal of dead skin cells with active regeneration to ensure the epidermal renewal cycle remains balanced.
These three additions reflect a strategic move by LipoTrue to offer formulators targeted tools for modern skincare challenges. By blending marine biotechnology with plant-based science, the company is positioning its new portfolio to serve product concepts focused on healthy aging and luminosity. The launch at booth V50 during the industry event highlights a commitment to translating complex biological perspectives into functional cosmetic solutions.
The Industry Pulse Bottom Line
LipoTrue’s new trio offers formulators advanced biotechnological tools that bridge the gap between nature-inspired science and clinical-grade performance, focusing on the essential pillars of luminosity, cellular longevity, and balanced epidermal renewal.